DalsnaFinance

Valneva $VALN

Health Care

France
Create a scorecard
$5.82
+0.07 (+1.31%)
As of Oct 5, 2026, 5:11 PM EDT
Price history
Loading chart…

Valneva (VALN) is trading up at $5.82 (+1.31%), as of the latest quote. It operates in the Health Care sector.

IPO: May 6, 2021 · $26.41 offering · NASDAQ · View IPO details →

Valneva revenue & net income history (FY2019–FY2025)

RevenueNet income
€361.3M€109.0M−€143.3MFY2019 revenue: €126.2MFY2019 net income: −€811.0K'19FY2020 revenue: €110.3MFY2020 net income: −€55.1M'20FY2021 revenue: €348.1MFY2021 net income: −€61.4M'21FY2022 revenue: €361.3MFY2022 net income: −€143.3M'22FY2023 revenue: €153.7MFY2023 net income: −€101.4M'23FY2024 revenue: €169.6MFY2024 net income: −€12.2M'24FY2025 revenue: €174.7MFY2025 net income: −€115.2M'25
Valneva annual financial statements
FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue€126.2M€110.3M€348.1M€361.3M€153.7M€169.6M€174.7M
Growth (year over year)—−12.6%+215.5%+3.8%−57.5%+10.3%+3.0%
Gross profit€73.4M€56.0M€160.2M€36.9M€52.8M€71.0M€67.5M
Gross margin58.2%50.8%46.0%10.2%34.4%41.9%38.7%
Operating income−€811.0K−€55.1M−€61.4M−€113.4M−€82.1M€13.3M−€82.1M
Operating margin−0.6%−50.0%−17.6%−31.4%−53.4%7.9%−47.0%
Net income−€811.0K−€55.1M−€61.4M−€143.3M−€101.4M−€12.2M−€115.2M
Net margin−0.6%−50.0%−17.6%−39.7%−66.0%−7.2%−66.0%
EPS (diluted)−€0.02−€0.71−€0.75−€1.24−€0.73−€0.08−€0.68
Balance sheet
Cash and equivalents€64.4M€204.4M€346.7M€286.5M€126.1M€168.3M€109.7M
Total assets—€449.2M€817.4M€621.3M€460.1M€500.0M€398.8M
Total liabilities—€371.7M€646.8M€401.5M€331.8M€318.8M€292.7M
Shareholders' equity€135.2M€77.4M€170.6M€219.8M€128.2M€181.3M€106.2M
Cash flow
Operating cash flow€5.53M€137.7M€76.9M−€245.3M−€202.7M−€67.2M−€52.9M
Capital expenditure€10.5M€18.9M€92.2M€29.2M€14.2M€13.9M€4.42M
Free cash flow−€4.97M€118.8M−€15.3M−€274.6M−€217.0M−€81.1M−€57.3M

From Valneva's 20-F and 6-K filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Amounts are in Euro (EUR), as reported, not converted to dollars. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Valneva

Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States.

Source: Wikipedia — Valneva SE

Headquarters
Saint-Herblain, France From SEC filings, Oct 2026

Recent News (1)

Other Health Care companies to compare with VALN

Browse all companies →